Table 1.
Demographic details, rheumatoid arthritis characteristics, and laboratory values of 40 rheumatoid arthritis patients at first presentation
| Demographic detail | Value |
| Male:female | 13:27 |
| Mean age (years) | 53 (22–78) |
| Male mean age (years) | 58 (37–78) |
| Female mean age (years) | 51 (22–72) |
| Body mass index (kg/m2) | 28 (17–45) |
| Rheumatoid arthritis characteristics | |
| Disease duration (months) | 7 (1.0–12) |
| Tender joint count (out of 53) | 19 (14) |
| Swollen joint count (out of 44) | 16 (10) |
| Patient's assessment of fatigue (visual analogue scale, maximum 100) | 38 (28) |
| Health assessment questionnaire score (maximum disability 24) | 4.4 (4.5) |
| Physician's global assessment of disease activity (maximum 100) | 41 (26) |
| Joint pain (visual analogue scale, maximum 100) | 50 (31) |
| Morning stiffness duration (min) | 195 (358) |
| Rheumatoid factor level | 228 (302) |
| Disease activity score (DAS 4v) | 4.39 (1.6) |
| Rheumatoid factor positive (n (%)) | 30 (75%) |
| Laboratory values | |
| Erythrocyte sedimentation rate (mm/hour) | 36.5 (24) |
| C-reactive protein (mg/l, normal <6) | 25.5 (23) |
| Haemoglobin (g/l) | 131 (15) |
| Cholesterol (mmol/l) | 5.0 (1.0) |
| Triglyceride (mmol/l) | 1.4 (0.9) |
| High-density lipoprotein level (mmol/l) | 1.5 (0.4) |
| Total high-density lipoprotein/cholesterol ratio (mmol/l) | 3.6 (1.2) |
| Low-density lipoprotein cholesterol (mmol) | 2.8 (0.7) |
| Antinuclear antibody titre >1:160 (n (%)) | 28 (70%) |
Data presented as mean (range) or mean (standard deviation), unless indicated otherwise.